
Drugmakers in China are shifting marketing budgets to AI medical search apps, embracing digital platforms as a sweeping anti-graft crackdown restricts traditional hospital visits.
Chinese drugmakers are shifting marketing budgets to AI-powered medical apps to connect with physicians. This change comes as a government graft crackdown limits traditional hospital visits and sales channels.

Drugmakers in China are shifting marketing budgets to AI medical search apps, embracing digital platforms as a sweeping anti-graft crackdown restricts traditional hospital visits.
Everything you use on the web — faster, and in your pocket.